SFTPA2 and lung carcinoma: Although PF is known to increase the risk of lung cancer, this association should strongly recommend a molecular screening for SRG, especially SFTPA1 and SFTPA2, which have recently been shown to be associated with a high risk of lung cancer, particularly in smokers [23].